Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Relapsed or Refractory Soft Tissue Sarcoma
NCT00297258Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2005
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of pazopanib in soft tissue sarcoma (STS), sponsored by GSK. Started Nov 2005; status: completed.
02
Drugs
pazopanib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00297258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00297258.